Jeffrey S. Heier Ocular Therapeutix, Inc (OCUL) insider trading activity
Jeffrey S. Heier is Chief Scientific Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 245,940 shares of OCUL, which is worth approximately $2.8 Million. The most recent transaction as insider was on Nov 24, 2025, when has been sold 3,469 shares (Common Stock) at a price of $12.04 per share, resulting in proceeds of $41,766. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
246K
5.38%
3M change
8.59%
12M change
Total Value Held
$2.8 Million
Jeffrey S. Heier Transaction History
JSH
Jeffrey S. Heier
Chief Scientific Officer
Bedford,, MA